Advertisement

The Sensitivity of Candida Species Isolated from Children with Diarrhea to Antifungal Compounds

  • G. Hasçelik
  • Y. Akyön
  • N. Yuluǧ
Part of the Federation of European Microbiological Societies Symposium Series book series (FEMS, volume 50)

Abstract

Candida species are opportunistic microorganisms which are members of the normal flora of the mucous membranes in the respiratory, gastrointestinal and female genital tracts. In the presence of suitable conditions, they may gain dominance and be associated with pathologic conditions 1. In the past 30 years, there has been a significant increase in the number of infections caused by Candida species 2.

Keywords

Antifungal Agent Candida Species Female Genital Tract Antifungal Compound Rectal Swab 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. Jawetz, J.L. Melnick and E.A. Adelberg, Medical mycology, in: “Review of Medical Microbiology”, 17th ed., pp. 318–337, Lange Medical Publications, Los Altos (1987).Google Scholar
  2. 2.
    E.D. Spitzer, S.J. Travis and G.S. Kobayashi, Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species, Eur. J. Clin. Microbiol, Infect. Dis., 7: 80 (1988).CrossRefGoogle Scholar
  3. 3.
    K.N. Nugent and K.R. Couchet, Effects of sublethal concentrations of amphotericin B on Candida albicans, J. Infect. Dis., 154: 665 (1986).PubMedCrossRefGoogle Scholar
  4. 4.
    Y. Akgün and F. Aksit, Klinik olgulardan izole edilen Kandida’larin antimikotiklere duyarliliklari, Mikrobivol. Bült., 15: 105 (1981).Google Scholar
  5. 5.
    M.R. Mc Ginnis and M.G. Rinaldi, Antifungal agents, in: “Antibiotics in Laboratory Medicine”, 2nd ed., pp. 223–281 V. Lorian, ed., Williams and Wilkins, Baltimore (1986).Google Scholar
  6. 6.
    K.S. Defever, W.L. Whelan, A.L. Rogers, E.S. Beneke, J.M. Veselenak and D.R. Soll, Candida albicans resistance to 5-fluorocytosine frequency of partially resistant strains among clinical isolates, Antimicrob.Agents Chemother., 22: 810 (1982).PubMedGoogle Scholar
  7. 7.
    R.J. Holt,Clinical problems with 5-fluorocytosine, Mykoseri, 21: 363 (1978).Google Scholar
  8. 8.
    S.P. Clissold and J. Van Cutsem, Overview of the antimicrobial activity of ketoconazole, in: “Ketoconazole Today:A Review of Clinical Experience”, H.E. Jones, ed., pp.5–12, ADIS Press Limited (1987).Google Scholar
  9. 9.
    J.P. Galgani et al., Comparison of relative susceptibilities of three antifungal agents as determined by unstandardized methods, Antimicrob Agents Chemother., 31: 1343 (1987).Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • G. Hasçelik
    • 1
  • Y. Akyön
    • 1
  • N. Yuluǧ
    • 1
  1. 1.Department of Microbiology, Faculty of MedicineHacettepe UniversityAnkaraTurkey

Personalised recommendations